DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-144640 | Pharmaceutics
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET
7.1 GLOBAL DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Sanofi Pasteur
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Pfizer Inc
16.3 Novartis AG
16.4 GlaxoSmithKline
16.5 Astellas Pharma US
16.6 Protein Sciences Corporation
16.7 Lanzhou Institute of Biological Products Co Ltd
16.8 Merck Sharp & Dohme Corp
16.9 Seqirus
16.10 Johnson & Johnson
16.11 AstraZeneca
16.12 Emergent BioSolutions Inc
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Market by Type :Immune DTaP Vaccine
Therapy DTaP Vaccine
Market by Application :
Adult
Pediatric
Companies
Sanofi Pasteur
Pfizer Inc
Novartis AG
GlaxoSmithKline
Astellas Pharma US
Protein Sciences Corporation
Lanzhou Institute of Biological Products Co Ltd
Merck Sharp & Dohme Corp
Seqirus
Johnson & Johnson
AstraZeneca
Emergent BioSolutions Inc
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.